CORONAVIRUS/Adimmune gets green light to start human trials of COVID-19 vaccine
08/20/2020 05:49 PM
Taipei, Aug. 20 (CNA) An experimental COVID-19 vaccine developed by Taiwanese maker Adimmune Corp. has been given the green light to start human trials, making it the first in the country to receive approval, Taiwan's Food and Drug Administration (FDA) said Thursday.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
More in CORONAVIRUS
![Taiwan rolls out new Moderna vaccine amid warnings of new COVID outbreak]()
Taiwan rolls out new Moderna vaccine amid warnings of new COVID outbreakTaiwan's Centers for Disease Control (CDC) started to roll out Moderna's COVID-19 vaccine against the Omicron subvariant XBB.1.5 Tuesday, urging people to get the shots as it ...09/26/2023 07:12 PM![Taiwan to roll out updated Moderna COVID vaccine starting Sept. 26]()
Taiwan to roll out updated Moderna COVID vaccine starting Sept. 26Taiwan will roll out Moderna's COVID-19 vaccine against the Omicron subvariant XBB starting Sept. 26, according to Centers for Disease Control (CDC) Director General Chuang ...09/20/2023 06:29 PM![Taiwan to roll out updated Moderna COVID vaccine by late September: CDC]()
Taiwan to roll out updated Moderna COVID vaccine by late September: CDCTaiwan plans to roll out Moderna's COVID-19 vaccine against the Omicron subvariant XBB.1.5 before the Sept. 29- Oct. 1 Mid-Autumn Festival holiday weekend, the Centers for ...09/19/2023 06:32 PM
Latest
- Society
More infections reported as Taiwan enters flu season: CDC
09/26/2023 10:15 PM - Society
Temp worker sentenced to 6 months for fire at Carrefour warehouse
09/26/2023 09:56 PM - Business
Hon Hai increases investment in U.S.-based AI startup
09/26/2023 09:17 PM - Business
Google says undersea cables created over 64,000 jobs in Taiwan
09/26/2023 08:38 PM - Sports
Taiwanese women's taekwondo athletes win silver medals at Asian Games
09/26/2023 08:20 PM